These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11794096)

  • 21. Autolytic debridement of a large, necrotic, fully occluded foot ulcer using a hydrocolloid dressing in a diabetic patient.
    Cuschieri L; Debosz J; Miiller P; Celis M
    Adv Skin Wound Care; 2013 Jul; 26(7):300-4. PubMed ID: 23777879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The application of "INDAR" manufactured insulin in the treatment of complications of diabetes mellitus].
    Pkhakadze OH; Saliuta MIu; Shadrina NM; Skybun VM; Lazariev OP
    Klin Khir; 2001 Aug; (8):68-9. PubMed ID: 11794127
    [No Abstract]   [Full Text] [Related]  

  • 23. [Urinary syndrome in patients with diabetic foot].
    Mazurok LM
    Klin Khir; 2001 Aug; (8):32-3. PubMed ID: 11794106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific guidelines for the diagnosis and treatment of peripheral arterial disease in a patient with diabetes and ulceration of the foot 2011.
    Schaper NC; Andros G; Apelqvist J; Bakker K; Lammer J; Lepantalo M; Mills JL; Reekers J; Shearman CP; Zierler RE; Hinchliffe RJ;
    Diabetes Metab Res Rev; 2012 Feb; 28 Suppl 1():236-7. PubMed ID: 22271745
    [No Abstract]   [Full Text] [Related]  

  • 25. [The optimization of the therapeutic action of ultrasonic cavitation in treating suppurative wounds in diabetic patients].
    Kuliev RA; Babaev RF
    Vestn Khir Im I I Grek; 1991; 147(7-8):34-7. PubMed ID: 1668928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correction of the immune disorders in patients with diabetes mellitus type II with complicated diabetic foot syndrome].
    Savon IL
    Klin Khir; 2011 Aug; (8):55-8. PubMed ID: 22013692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of prostaglandin E1 and systemic antibacterial therapy application in patients with diabetes mellitus and purulent-necrotic lesions of the foot].
    Podpriatov SIe; Hrabovyĭ OM; Salata VV; Zaĭtsev SV; Simonova ZIe; Korbut SM; Shyshova SIa; Rohacheva VP
    Klin Khir; 2010; (11-12):76-8. PubMed ID: 21268804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human acellular dermal wound matrix for complex diabetic wounds.
    Rupert P
    J Wound Care; 2016 Apr; 25(4):S17-8, S20-1. PubMed ID: 27068343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Necrotic-inflammatory affection of foot in patients with diabetes mellitus. Terminology and classification].
    Fedorenko VP
    Klin Khir; 2000 Aug; (8):53-5. PubMed ID: 11036318
    [No Abstract]   [Full Text] [Related]  

  • 30. [New approaches to the choice of treatment and possibility of prognosis of the results in patients with diabetic foot].
    Ivashchenko VV
    Klin Khir; 2001 Aug; (8):17-9. PubMed ID: 11794099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries].
    Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD
    Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The aspects of cellular immunity in patients with diabetes mellitus and diabetic foot syndrome and its treatment by enteric sorbent "Silard P"].
    Shidlovs'kyĭ VO; Prokopchuk AI
    Klin Khir; 1997; (11-12):45-6. PubMed ID: 9615001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Boundaries of competence and responsibility of a surgeon in the treatment of patients with diabetes mellitus complicated by necrotic-inflammatory affection of foot].
    Fedorenko VP; Fedorenko AV; Smereka AV; Boĭko RL
    Klin Khir; 2002 Jul; (7):38-42. PubMed ID: 12378912
    [No Abstract]   [Full Text] [Related]  

  • 34. [A magnetic field in the combined treatment of suppurative wounds in diabetes mellitus].
    Kuliev RA; Babaev RF
    Vestn Khir Im I I Grek; 1992 Jan; 148(1):33-6. PubMed ID: 1338829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of oxytocin in the combined treatment of suppurative-necrotic lesions of the feet in diabetic patients].
    Gavrilenko VG; Stadnikov AA; Esipov VK; Mit'kin AF
    Vestn Khir Im I I Grek; 2000; 159(3):59-62. PubMed ID: 10983343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection and treatment of lower extremity neuropathy in patients with diabetic foot].
    Kucherenko NV; Skrypova TV; Liutkevych VF; Turans'kyĭ AI; Skybun VM
    Klin Khir; 2001 Aug; (8):22-4. PubMed ID: 11794101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linezolid penetration into wound tissue of two diabetic patients before and after hyperbaric oxygen therapy.
    Koomanachai P; Keel RA; Johnson-Arbor KK; Suecof LA; Nicolau DP; Kuti JL
    Undersea Hyperb Med; 2011; 38(1):11-6. PubMed ID: 21384759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of purulent-necrotic diseases in patients with diabetes mellitus].
    Genyk SN; Grushetskiĭ NN; Gonchar MG; Krysa VM; Martyn AS
    Klin Khir (1962); 1992; (3):49-53. PubMed ID: 1619870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Foot problems and foot care practices in diabetes. A survey of public and private diabetes clinics affiliated with a university hospital.
    Pugh KB; Jenkins AJ; Zheng D; Chinniss S; Hermayer K; Jenkins C
    J S C Med Assoc; 2002 Dec; 98(8):305-10. PubMed ID: 12532656
    [No Abstract]   [Full Text] [Related]  

  • 40. [Efficacy of different methods of ozone therapy in vascular complications of diabetes mellitus].
    Kulikov AG; Turova EA; Shcherbina TM; Kisileva OM
    Vopr Kurortol Fizioter Lech Fiz Kult; 2002; (5):17-20. PubMed ID: 12532590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.